Could a simple steroid improve stroke recovery? major trial launches
NCT ID NCT07141303
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether giving the steroid methylprednisolone right after a stroke clot removal procedure can help patients recover better. About 1060 adults who had a large-vessel stroke will receive either the drug or a placebo. The goal is to see if the drug reduces disability, brain swelling, and bleeding without causing serious side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methylprednisolone sodium succinate (a steroid anti-inflammatory drug)
- What this could lead to
- If it works, this could become a standard add-on treatment to improve recovery and reduce brain swelling after stroke clot removal.
- What could go wrong
- This is a Phase 3 trial, but steroids can increase infection risk and bleeding. The benefit may be small or not outweigh risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tangdu Hospital
RECRUITINGXi'an, Shaanxi, 710038, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?